Connor D - Search Results

1

Authors reply: Polymerisation of cyanoacrylates: The effect of sclero-embolic and contrast agents.

Gracé J, Connor D, Parsi K. Gracé J, et al. Among authors: connor d. Phlebology. 2024 Aug 4:2683555241271932. doi: 10.1177/02683555241271932. Online ahead of print. Phlebology. 2024. PMID: 39097826 No abstract available.

2

Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.

Star P, Connor DE, Parsi K. Star P, et al. Phlebology. 2018 Apr;33(3):150-162. doi: 10.1177/0268355516687864. Epub 2017 Feb 6. Phlebology. 2018. PMID: 28166694 Review.

3

Circulating blood cells influence the fibrinolytic capacity of clots generated in the presence of detergent sclerosants.

Li T, Connor D, Parsi K. Li T, et al. Among authors: connor d. Phlebology. 2020 May;35(4):273-280. doi: 10.1177/0268355519860724. Epub 2019 Jul 19. Phlebology. 2020. PMID: 31324121 No abstract available.

4

Cyanoacrylate closure for peripheral veins: Consensus document of the Australasian College of Phlebology.

Parsi K, Roberts S, Kang M, Benson S, Baker L, Berman I, Bester LJ, Connor DE, Dinnen P, Grace J, Stirling A, Ibrahim N, Lekich C, Lim A, Matar L, Nadkarni S, Paraskevas P, Rogan C, Thibault PK, Thibault S, van Rij A, Yang A. Parsi K, et al. Phlebology. 2020 Apr;35(3):153-175. doi: 10.1177/0268355519864755. Epub 2019 Aug 1. Phlebology. 2020. PMID: 31368408 Review. No abstract available.

5

Foam bubble size is significantly influenced by sclerosant concentration for polidocanol but not sodium tetradecyl sulphate.

Wong K, Connor DE, Andrade OC, Parsi K. Wong K, et al. Phlebology. 2021 Aug;36(7):576-587. doi: 10.1177/0268355521995012. Epub 2021 Mar 18. Phlebology. 2021. PMID: 33736561

6

LIPIODOL reduces the lytic activity of detergent sclerosants in vitro.

Gracé J, Connor D, Bester L, Rogan C, Parsi K. Gracé J, et al. Among authors: connor d. Phlebology. 2021 Dec;36(10):771-778. doi: 10.1177/02683555211018312. Epub 2021 May 27. Phlebology. 2021. PMID: 34039085

7

Chronic venous disease, platelet and haemostatic abnormalities contribute to the pathogenesis of pigmented purpuric dermatoses.

Parsi K, Kim B, O'Connor AA, Kadam P, Connor D. Parsi K, et al. Among authors: connor d. Phlebology. 2022 Jun;37(5):348-360. doi: 10.1177/02683555221075813. Epub 2022 Mar 23. Phlebology. 2022. PMID: 35319303

8

Treatment of venous malformations with tumescent-assisted sclero-embolic and ablative lasers (SEALs): Safe and effective long-term outcomes.

Kang M, Connor DE, Parsi K. Kang M, et al. Phlebology. 2022 Jun;37(5):367-380. doi: 10.1177/02683555221080045. Epub 2022 Mar 28. Phlebology. 2022. PMID: 35344460

9

899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: The untold story of cyanoacrylate adhesive closure.

Parsi K, Zhang L, Whiteley MS, Vuong S, Kang M, Naidu N, Grace J, Connor DE. Parsi K, et al. Phlebology. 2024 Mar;39(2):80-95. doi: 10.1177/02683555231211086. Epub 2023 Oct 30. Phlebology. 2024. PMID: 37902099

10

Polymerisation of cyanoacrylates: The effect of sclero-embolic and contrast agents.

Gracé J, Connor D, Bester L, Rogan C, Parsi K. Gracé J, et al. Among authors: connor d. Phlebology. 2024 Mar;39(2):114-124. doi: 10.1177/02683555231214343. Epub 2023 Nov 9. Phlebology. 2024. PMID: 37944534

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

660 results

Search Page

Filters